scholarly article | Q13442814 |
P50 | author | Denny L Cottle | Q42755641 |
Sebastian Dworkin | Q42799609 | ||
Charbel Darido | Q58876642 | ||
P2093 | author name string | Alana Auden | |
Seema Srivastava | |||
Stephen M Jane | |||
Ian M Smyth | |||
Fiona H Tan | |||
Stephen J Goldie | |||
Rhys Brady | |||
Suraya Roslan | |||
Darren D Partridge | |||
P2860 | cites work | Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector | Q24312084 |
Epidermal wound repair is regulated by the planar cell polarity signaling pathway | Q24339352 | ||
The CC chemokines MDC and TARC induce platelet activation via CCR4 | Q28177034 | ||
The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4 | Q28239606 | ||
Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases | Q28253402 | ||
The Grainyhead-like epithelial transactivator Get-1/Grhl3 regulates epidermal terminal differentiation and interacts functionally with LMO4 | Q28505730 | ||
A homolog of Drosophila grainy head is essential for epidermal integrity in mice | Q28585220 | ||
A GRHL3-regulated repair pathway suppresses immune-mediated epidermal hyperplasia | Q28587867 | ||
Identification of a Novel Proto-oncogenic Network in Head and Neck Squamous Cell Carcinoma | Q28834533 | ||
Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function | Q30306721 | ||
Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes | Q30638019 | ||
Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity | Q32156624 | ||
Tumor formation initiated by nondividing epidermal cells via an inflammatory infiltrate | Q34358943 | ||
Clinical significance of serum thymus and activation-regulated chemokine in gastric cancer: potential as a serum biomarker. | Q35713297 | ||
The cornified envelope: a model of cell death in the skin | Q36085605 | ||
Chemokine CCL17 induced by hypoxia promotes the proliferation of cervical cancer cell | Q36309396 | ||
Stem cells behind the barrier. | Q38118084 | ||
Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis | Q38195864 | ||
Epidermal barrier in hereditary ichthyoses, atopic dermatitis, and psoriasis. | Q38619156 | ||
Two Ancient Gene Families Are Critical for Maintenance of the Mammalian Skin Barrier in Postnatal Life. | Q38786479 | ||
The role of barrier genes in epidermal malignancy | Q38797349 | ||
A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin. | Q40853609 | ||
Tumor-associated macrophage or chemokine ligand CCL17 positively regulates the tumorigenesis of hepatocellular carcinoma | Q40968092 | ||
Inhibition of binding of interferon-gamma to its receptor by salicylates used in inflammatory bowel disease | Q41599875 | ||
Fetal inhibition of inflammation improves disease phenotypes in harlequin ichthyosis. | Q41744100 | ||
Sox2 modulates the function of two distinct cell lineages in mouse skin | Q42001929 | ||
Stratum corneum TARC level is a new indicator of lesional skin inflammation in atopic dermatitis. | Q43107214 | ||
Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides | Q44274756 | ||
Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis. | Q48054446 | ||
Pigmented purpuric dermatitis with high expression levels of serum TARC/CCL17 and epidermal TSLP. | Q54646998 | ||
Psoriasis | Q58235916 | ||
Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris | Q73778362 | ||
TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma | Q74071941 | ||
Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis | Q74445337 | ||
Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease | Q74615775 | ||
CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli | Q79951348 | ||
Serum levels of thymus and activation-regulated chemokine can be used in the clinical evaluation of atopic dermatitis | Q85458810 | ||
Serum thymus and activation-regulated chemokine as disease activity and response biomarker in alopecia areata | Q86489325 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunology | Q101929 |
cell biology | Q7141 | ||
keratinocyte | Q1473931 | ||
cancer research | Q3421914 | ||
P304 | page(s) | 1072 | |
P577 | publication date | 2018-10-19 | |
P1433 | published in | Cell Death and Disease | Q2197222 |
P1476 | title | Loss of GRHL3 leads to TARC/CCL17-mediated keratinocyte proliferation in the epidermis | |
P478 | volume | 9 |
Q91739345 | Skin transcriptome profiling of Changthangi goats highlights the relevance of genes involved in Pashmina production |
Q91795960 | Targeted Therapy Against the Cell of Origin in Cutaneous Squamous Cell Carcinoma |
Q104136822 | Topical Aminosalicylic Acid Improves Keratinocyte Differentiation in an Inducible Mouse Model of Harlequin Ichthyosis |
Search more.